Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cartilage metabolism modulation refers broadly to altering the metabolic activity of chondrocytes and the dynamic balance between anabolic and catabolic processes that determine cartilage integrity. This includes regulating glucose uptake, glycolytic activity, mitochondrial function, oxidative stress, and the expression of key ECM components such as collagen II, aggrecan, and matrix-degrading enzymes (such as MMPs and ADAMTS5)[2][3][5]. Dysregulation of these metabolic processes, frequently induced by inflammation and aging, is central to the pathophysiology of osteoarthritis and cartilage degeneration. Therapeutic approaches seek to restore the balance of cartilage matrix metabolism by modulating specific enzymes, transcription factors, and signaling molecules involved in ECM synthesis/degradation, energy metabolism (e.g., AMPK, SIRT1), and inflammatory pathways[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cartilage metabolism modulation.